AM630 is an inverse agonist at the human cannabinoid CB1 receptor

被引：46
作者：
Landsman, RS
Makriyannis, A
Deng, HF
Consroe, P
Roeske, WR
Yamamura, HI [1 ]
机构：
[1] Univ Arizona, Hlth Sci Ctr, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA
[2] Univ Arizona, Hlth Sci Ctr, Dept Pharmacol & Toxicol, Tucson, AZ 85724 USA
[3] Univ Arizona, Hlth Sci Ctr, Dept Biochem, Tucson, AZ 85724 USA
[4] Univ Arizona, Hlth Sci Ctr, Dept Med, Tucson, AZ 85724 USA
[5] Univ Arizona, Hlth Sci Ctr, Dept Psychiat, Tucson, AZ 85724 USA
[6] Univ Arizona, Hlth Sci Ctr, Program Neurosci, Tucson, AZ 85724 USA
[7] Univ Connecticut, Sch Pharm, Storrs, CT 06269 USA
来源：
LIFE SCIENCES | 1998年 / 62卷 / 09期
关键词：
human cannabinoid CB1 receptor; inverse agonism; AM630; WIN 55,212-2; GTP gamma S; CHO cells; inverse agonist; negative intrinsic activity;
D O I：
10.1016/S0024-3205(97)01187-9
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The present investigation examines WIN 55,212-2 and AM630 at the cloned human cannabinoid CB1, receptor stably expressed in Chinese hamster ovary (CHO) cells. The effect of various concentrations of WIN 55,212-2 and AM630 on basal [S-35]GTP gamma S binding to cell membranes was determined. WIN 55,212-2 (100 mu M) stimulated basal [S-35]GTP gamma S binding 77.9% with an EC50 value of 0.36 mu M. Conversely, AM630 (100 mu M) inhibited basal [S-35]GTP gamma S binding by 20.9% with an EC50 value of 0.90 mu M These results show that WIN 55,212-2 is an agonist and AM630 is an inverse agonist in this system. (C) 1998 Elsevier Science Inc.
引用
收藏
页码：PL109 / PL113
页数：5
相关论文
共 50 条
[21]   Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors [J].
MacLennan, SJ ;
Reynen, PH ;
Kwan, J ;
Bonhaus, DW .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (04) :619-622
[22]   Binding of the Hemopressin Peptide to the Cannabinoid CB1 Receptor: Structural Insights [J].
Scrima, Mario ;
Di Marino, Sara ;
Grimaldi, Manuela ;
Mastrogiacomo, Antonia ;
Novellino, Ettore ;
Bifulco, Maurizio ;
D'Ursi, Anna Maria .
BIOCHEMISTRY, 2010, 49 (49) :10449-10457
[23]   Use of cannabinoid CB1 receptor antagonists for the treatment of metabolic disorders [J].
Scheen, Andre J. ;
Paquot, Nicolas .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (01) :103-116
[24]   Effects of the cannabinoid CB1-receptor neutral antagonist AM4113 and antagonist/inverse agonist rimonabant on fentanyl discrimination in male rats [J].
AlKhelb, Dalal ;
Kirunda, Andre ;
Ho, Thanh C. ;
Makriyannis, Alexandros ;
Desai, Rajeev I. .
DRUG AND ALCOHOL DEPENDENCE, 2022, 240
[25]   Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties [J].
Bergman, Jack ;
Delatte, Marcus S. ;
Paronis, Carol A. ;
Vemuri, Kiran ;
Thakur, Ganesh A. ;
Makriyannis, Alex .
PHYSIOLOGY & BEHAVIOR, 2008, 93 (4-5) :666-670
[26]   Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gαi/o protein inhibitor [J].
Porcu, Alessandra ;
Melis, Miriam ;
Turecek, Rostislav ;
Ullrich, Celine ;
Mocci, Ignazia ;
Bettler, Bernhard ;
Gessa, Gian Luigi ;
Castelli, M. Paola .
NEUROPHARMACOLOGY, 2018, 133 :107-120
[27]   CB1 cannabinoid receptor agonist mouse VD-hemopressin(α) produced supraspinal analgesic activity in the preclinical models of pain [J].
Zheng, Ting ;
Zhang, Run ;
Zhang, Ting ;
Zhang, Meng-Na ;
Xu, Biao ;
Song, Jing-jing ;
Li, Ning ;
Tang, Hong-Hai ;
Wang, Pei ;
Wang, Rui ;
Fang, Quan .
BRAIN RESEARCH, 2018, 1680 :155-164
[28]   Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands [J].
Nevalainen, Tapio .
CURRENT MEDICINAL CHEMISTRY, 2014, 21 (02) :187-203
[29]   3-Substituted Pyrazole Analogs of the Cannabinoid Type 1 (CB1) Receptor Antagonist Rimonabant: Cannabinoid Agonist-Like Effects in Mice via Non-CB1, Non-CB2 Mechanism [J].
Wiley, Jenny L. ;
Selley, Dana E. ;
Wang, Pinglang ;
Kottani, Rudresha ;
Gadthula, Srinivas ;
Mahadeven, Anu .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 340 (02) :433-444
[30]   Novel selective cannabinoid CB1 receptor antagonist MJ08 with potent in vivo bioactivity and inverse agonistic effects [J].
Chen, Wei ;
Xu, Cheng ;
Liu, Hong-ying ;
Long, Long ;
Zhang, Wei ;
Zheng, Zhi-bing ;
Xie, Yun-de ;
Wang, Li-li ;
Li, Song .
ACTA PHARMACOLOGICA SINICA, 2011, 32 (09) :1148-1158
12345